Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MT-ND4L Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA567392
Description
Immunogen sequence: LLVSISNTYGL DYVHNLNLLQ Highest antigen sequence identity to the following orthologs - mouse 81%, rat 86%.
NADH:ubiquinone oxidoreductase (complex I) is an extremely complicated multiprotein complex located in the inner mitochondrial membrane. Human complex I is important for energy metabolism because its main function is to transport electrons from NADH to ubiquinone, which is accompanied by translocation of protons from the mitochondrial matrix to the intermembrane space. Human complex I appears to consist of 41 subunits. A small number of complex I subunits are the products of mitochondrial genes (subunits 1-7), while the remainder are nuclear encoded and imported from the cytoplasm. NADH dehydrogenase subunit 4L (ND4L) is most likely a component of the hydrophobic protein fragment of Complex I. Mutations in the gene encodiing for ND4 are implicated in Leber hereditary optic neuropathy, a rare condition that can cause loss of central vision.
Specifications
MT-ND4L | |
Polyclonal | |
Unconjugated | |
MT-ND4L | |
mitochondrially encoded NADH 4L dehydrogenase; MTND4L; mt-Nd4l; NADH dehydrogenase subunit 4L; NADH4L; NADH-ubiquinone oxidoreductase chain 4L; Nd4l | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
4539 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
P03901 | |
MT-ND4L | |
Recombinant Human MT-ND4L. Recombinant protein control fragment (Product #RP-108057). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction